Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumors
- 15 November 1990
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 46 (5) , 878-883
- https://doi.org/10.1002/ijc.2910460521
Abstract
Phenotypic and functional characteristics of tumor-infiltrating lymphocytes (TIL) obtained from human primary and metastatic liver tumors were studied. Lymphocytes isolated from 18 tumors and autologous (A) peripheral blood (6 cases) were phenotyped by 2-color flow cytometry and cloned in a limiting dilution system, which allows virtually all normal T lymphocytes to proliferate; 70-80% of fresh TIL were T cells (i.e., CD3+), and the ratio of CD4+/CD8+ cells was 1.2 in both primary nad metastatic liver tumors. TIL contained significantly more CD56+ (NKHI+) cells, half of which were CD3+CD56+, CD3+CD25+ cells and CD3+HLA-DR+ cells, than A-PBL. The frequencies of proliferating T-cell precursors (PTL-p) and cytolytic T-lymphocyte precursors (CTL-p) reactive with K562, allogeneic tumor cells and autologous tumor cells, were determined. Mean PTL-p frequencies for TIL from hepatocellular carcinomas, cholangiocarcinomas and metastatic liver tumors were 052 (0.22-0.83), 0.10 (0.05-0.16) and 0.16 (0.01-0.30), respectively. The frequency of CTL-p with natural-killer-like activity was lower in TIL than in A-PBL. The frequency of CTL-p for autologous tumor cells in fresh TIL isolated from primary liver tumors was 0.02-0.13 and 12/81 clones were reactive against autologous tumor. In contrast, only 1/66 TIL clones obtained from colon carcinomas metastatic to liver showed autotumor reactivity. No clones reactive with autologous tumor were obtained from peripheral blood of patients with liver cancer. These data indicate that substantial differences in anti-tumor functions of TIL between primary and metastatic liver tumors exist, which can be detected at a clonal level.This publication has 29 references indexed in Scilit:
- Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma.The Journal of Experimental Medicine, 1989
- Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.The Journal of Experimental Medicine, 1988
- Separation, phenotyping and limiting dilution analysis of T‐lymphocytes infiltrating human solid tumorsInternational Journal of Cancer, 1986
- Separation of tumor-infiltrating lymphocytes from tumor cells in human solid tumorsJournal of Immunological Methods, 1986
- Inhibition of Lymphocyte Proliferation by a Synthetic Peptide Homologous to Retroviral Envelope ProteinsScience, 1985
- Clonal analysis of cytotoxic T‐lymphocyte response to autologous human metastatic melanomaInternational Journal of Cancer, 1985
- Immunosuppressive activity of the retroviral envelope protein P 15E and its possible relationship to neoplasiaImmunology Today, 1984
- Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity.The Journal of Experimental Medicine, 1983
- Quantitation of proliferative and cytotoxic precursor cells directed against human tumours: Limiting dilution analysis in peripheral blood and at the tumour siteInternational Journal of Cancer, 1982
- Prognostic significance of the histological features of malignant melanomaHistopathology, 1979